Evidence map›Paper›PMID 21498673›Full record

ArticleBlood2011

Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.

Isabel Barao, Maite Alvarez, Erik Ames, Mark T Orr, Heather E Stefanski, Bruce R Blazar, Lewis L Lanier, Stephen K Anderson, Doug Redelman, William J Murphy

Abstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Isabel BaraoDepartment of Microbiology and Immunology, University of Nevada, Reno, Reno, NV, USA.
Maite Alvarez
Erik Ames
Mark T Orr
Heather E Stefanski
Bruce R Blazar
Lewis L Lanier
Stephen K Anderson
Doug Redelman
William J Murphy

Funding

Trial Design and Biostatistical Support CoreP01CA065493 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1995 to 2026
$48.2M
UNDERGRADUATE RESEARCH AND TRAININGP20RR016464 · NCRR · UNIVERSITY OF NEVADA RENO · PI REIBER, CARL · 2001 to 2011
$30.3M
Molecular Studies of Cellular CytotoxicityZIABC010013 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ANDERSON, STEPHEN K · 2009 to 2025
$17.2M
Positive and Negative Regulation of Natural Killer Cells After BMTR01HL089905 · NHLBI · UNIVERSITY OF NEVADA RENO · PI MURPHY, WILLIAM JOSEPH · 2007 to 2015
$3.1M
INVASIVE GLIOMA CELLSF32CA067493 · NCI · WASHINGTON UNIVERSITY · PI CHICOINE, MICHAEL R · 1995 to 1996
–
CCR NIH HHS HHSN261200800001CIntramural NIH HHSNCI NIH HHS F32 CA067493NCI NIH HHS HHSN261200800001ENCI NIH HHS P01 CA065493NCI NIH HHS P01CA067493NCRR NIH HHS P20 RR016464NHLBI NIH HHS R01 HL089905NHLBI NIH HHS R01HL089905PHS HHS A1068129
6 · The paper itself

Abstract

Natural killer (NK) cell subsets can be defined by the differential expression of inhibitory receptors for MHC class I molecules. Early after congenic HSCT, we found that Ly49G2(high) single-positive NK cells repopulated, displayed an activated phenotype, and were highly cytolytic. Over time, this subset was replaced with NK cells with a normal pattern of Ly49 expression. Treatment of mice with IL-2 also resulted in the rapid expansion of these Ly49G2(high) single-positive NK cells. Only the Ly49g (Klra7) Pro1 transcript was highly induced in both HSCT- and IL-2-treated recipients. MHC-independent expansion of the Ly49G2(+) subset was also observed after Listeria monocytogenes or mouse cytomegalovirus infection. Our data indicate that during reconstitution after HSCT and various activation stimuli, Ly49G2(+) NK cells represent the "first-responder" NK cells, which occur independently of NK-cell licensing via Ly49-MHC interactions. These data suggest that the inhibitory Ly49G2 receptor represents an activation marker on mouse NK cells under various conditions.

Indexed as

Graft SurvivalHematopoietic Stem Cell TransplantationLymphocyte ActivationMajor Histocompatibility ComplexAnimalsBiomarkersCell Line, TumorCells, CulturedCytomegalovirusFemaleGene Expression RegulationInterleukin-2Killer Cells, NaturalListeria monocytogenesMiceMice, CongenicBiomarkersIL2 protein, humanInterleukin-2Ly49G2 receptorReceptors, ImmunologicRecombinant Proteins

Identifiers

PMID21498673
PMCPMC3143551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.